Amgen
A Senior Process Development Scientist joins the Drug Substance Technologies group to invent and develop manufacturing processes for hybrid modalities including antibody drug conjugates, synthetic peptides, and oligonucleotides. The role involves applying synthetic and bioconjugation chemistry expertise to scale processes from early development to commercial manufacturing while ensuring regulatory compliance. Candidates will drive technology innovation, support technology transfer, and collaborate cross-functionally to advance Amgen's pipeline of innovative medicines.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
11% above the average for this role
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago